<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="announcement">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Behav Brain Res</journal-id>
      <journal-title>Behavioural Brain Research</journal-title>
      <issn pub-type="ppub">0166-4328</issn>
      <issn pub-type="epub">1872-7549</issn>
      <publisher>
        <publisher-name>Elsevier/North-Holland Biomedical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2614086</article-id>
      <article-id pub-id-type="pmid">18762217</article-id>
      <article-id pub-id-type="publisher-id">BBR5591</article-id>
      <article-id pub-id-type="doi">10.1016/j.bbr.2008.07.039</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Distribution and neurochemical characterization of neurons within the nucleus of the solitary tract responsive to serotonin agonist-induced hypophagia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lam</surname>
            <given-names>Daniel D.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Ligang</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vegge</surname>
            <given-names>Andreas</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xiu</surname>
            <given-names>Philip Y.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Christensen</surname>
            <given-names>Britt T.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Osundiji</surname>
            <given-names>Mayowa A.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yueh</surname>
            <given-names>Chen-yu</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">d</xref>
          <xref rid="aff5" ref-type="aff">e</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Evans</surname>
            <given-names>Mark L.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Heisler</surname>
            <given-names>Lora K.</given-names>
          </name>
          <email>lkh30@medschl.cam.ac.uk</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <addr-line><sup>a</sup>Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK</addr-line>
      </aff>
      <aff id="aff2">
        <addr-line><sup>b</sup>Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA</addr-line>
      </aff>
      <aff id="aff3">
        <addr-line><sup>c</sup>Department of Veterinary Pathobiology, Faculty of Life Sciences, University of Copenhagen, Dyrlaegevej 88, 1870 Frederiksberg, Denmark</addr-line>
      </aff>
      <aff id="aff4">
        <addr-line><sup>d</sup>Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, University of Cambridge, Cambridge CB2 2QQ, UK</addr-line>
      </aff>
      <aff id="aff5">
        <addr-line><sup>e</sup>College of Medicine, Chang Gung University, Chang Gung Memorial Hospital, Chiayi, Taiwan, ROC</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author. <email>lkh30@medschl.cam.ac.uk</email></corresp>
        <fn id="fn1">
          <label>1</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>03</day>
        <month>1</month>
        <year>2009</year>
      </pub-date>
      <volume>196</volume>
      <issue>1</issue>
      <fpage>139</fpage>
      <lpage>143</lpage>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>7</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>25</day>
          <month>7</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>7</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2009 Elsevier B.V.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Elsevier B.V.</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p>Pharmacological compounds enhancing serotonergic tone significantly decrease food intake and are among the most clinically efficacious treatments for obesity. However, the central mechanisms through which serotonergic compounds modulate feeding behavior have not been fully defined. The primary relay center receiving visceral gastrointestinal information in the central nervous system is the nucleus of the solitary tract (NTS) in the caudal brainstem. Here we investigated whether the classic anorectic serotonin receptor agonist <italic>m</italic>-chloro-phenylpiperazine (mCPP) enhances the activity of metabolically sensitive NTS neurons. Using <italic>c-fos</italic> immunoreactivity (FOS-IR) as a marker of neuronal activation in rats, we observed that mCPP significantly and dose-dependently activated a discrete population of caudal NTS neurons at the level of the area postrema (AP). In particular, this pattern of FOS-IR induction was consistent with the location of catecholamine-containing neurons. Dual-labeling performed with FOS-IR and the catecholamine biosynthetic enzyme tyrosine hydroxylase (TH) revealed that mCPP induced FOS-IR in 83.7% of TH-IR containing neurons in the NTS at the level of the AP. The degree of activation of TH neurons was strongly negatively correlated with food intake. Moreover, this activation was specific to catecholamine neurons, with negligible induction of cocaine- and amphetamine-regulated transcript (CART), cholecystokinin (CCK), glucagon-like peptide 1 (GLP-1), or neurotensin neurons. NTS catecholaminergic neurons relay visceral gastrointestinal signals to both the lateral hypothalamus (LHA) and paraventricular nucleus of the hypothalamus (PVH), where these signals are integrated into autonomic and hormonal responses regulating food intake. The data presented here identify a novel mechanism through which a serotonin receptor agonist acting in the caudal brainstem may regulate ingestive behavior.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Serotonin</kwd>
        <kwd>mCPP</kwd>
        <kwd>Nucleus of the solitary tract</kwd>
        <kwd>Tyrosine hydroxylase</kwd>
        <kwd>Catecholamine</kwd>
        <kwd>Food intake</kwd>
        <kwd>Rat</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Despite the rapidly increasing incidence of obesity, the mechanisms underlying the physiological control of feeding and body weight are only partially understood. The neurotransmitter serotonin (5-HT) is an important regulator of ingestive behavior. Depletion of brain serotonin levels produces hyperphagia and weight gain <xref rid="bib3 bib27" ref-type="bibr">[3,27]</xref>, whereas drugs which increase serotonin availability have an anorectic effect. One of the most extensively studied anorectic serotonin receptor (5-HTR) agonists is <italic>m</italic>-chloro-phenylpiperazine (mCPP), a compound that reduces food intake following peripheral and central administration <xref rid="bib2 bib13 bib14 bib28" ref-type="bibr">[2,13,14,28]</xref>. mCPP decreases feeding rate and advances satiety in a similar manner to a food pre-load <xref rid="bib15 bib32" ref-type="bibr">[15,32]</xref>. Thus, mCPP appears to reduce food intake by enhancing post-ingestive satiety.</p>
    <p>Integral to the serotonergic regulation of food intake are serotonin neurons in the midbrain raphe nuclei that project to established hypothalamic feeding centers, including the arcuate (ARC) and paraventricular (PVH) hypothalamic nuclei. Specifically, serotonin engages melanocortin pathways in the ARC to inhibit feeding <xref rid="bib9 bib10 bib16" ref-type="bibr">[9,10,16]</xref>, while serotonin injected into the PVH has an anorectic effect <xref rid="bib31" ref-type="bibr">[31]</xref>.</p>
    <p>In addition to the hypothalamus, the caudal brainstem also appears to be an important mediator of serotonergic effects on feeding. Chronically decerebrate rats, which lack direct neural connections between the hindbrain and forebrain, significantly reduce food intake in a manner comparable to intact rats when treated with peripheral doses of mCPP or <sc>d</sc>-fenfluramine, a drug which increases serotonin release and inhibits serotonin reuptake <xref rid="bib8 bib12" ref-type="bibr">[8,12]</xref>. In addition, mCPP-induced hypophagia is blocked by fourth ventricle infusion of mesulergine, a 5-HT<sub>2C/2A</sub>R antagonist, providing indirect support for a brainstem locus of action <xref rid="bib12" ref-type="bibr">[12]</xref>. In an effort to identify specific brain regions responsive to serotonergic hypophagia, surveys of associated c-fos immunoreactivity (FOS-IR) induction have been performed. Of note, anorectic doses of fenfluramine robustly increase neuronal activation in brainstem regions, including the nucleus of the solitary tract (NTS) <xref rid="bib17 bib26" ref-type="bibr">[17,26]</xref>.</p>
    <p>The NTS is of particular interest because the majority of gustatory and gastrointestinal afferent pathways have their first synaptic relay in this region. Thus, NTS neurons are activated by visceral satietogenic signals such as gastric distension <xref rid="bib22 bib34" ref-type="bibr">[22,34]</xref> and intestinal nutrients <xref rid="bib36" ref-type="bibr">[36]</xref>, as well as by meal ingestion <xref rid="bib6 bib23" ref-type="bibr">[6,23]</xref>. Projections arising from the NTS relay gastrointestinal signals to hypothalamic regions involved in autonomic and hormonal control. In addition, second-order NTS neurons synapse on motor neurons in the dorsal motor nucleus of the vagus (DMV) which control ingestive and digestive function <xref rid="bib21" ref-type="bibr">[21]</xref>. These connections represent a series of reflex pathways regulating eating rate and meal size. These reflex pathways are modulated by long-term energy signals both through direct effects of these signals in the caudal brainstem, and by reciprocal efferents from hypothalamic centers, where these long-term signals are integrated. For example, NTS neurons responsive to gastric vagal nerve stimulation are also activated by electrical stimulation of the PVH, a key feeding center <xref rid="bib25" ref-type="bibr">[25]</xref>.</p>
    <p>In the present study, we investigated whether anorexia associated with serotonergic agonists like mCPP is correlated with the activation of a discrete population of NTS neurons. Specifically, we mapped FOS-IR induction produced by hypophagic doses of mCPP in the rostrocaudal extent of the NTS.</p>
    <p>As a first step to investigate the central pathways involved in mCPP-induced hypophagia, we investigated the anorectic effect of mCPP at the onset of the dark cycle in <italic>ad libitum</italic> fed rats. All animal experiments were carried out in accordance with the “Principles of laboratory animal care” (NIH) and UK Home Office regulations. Experiments were carried out using adult male Sprague–Dawley rats weighing 280–300 g (Taconic), individually housed with water and rat chow pellets available <italic>ad libitum</italic> in a light-controlled (12 h on/12 h off) and temperature-controlled (21.5–22.5 °C) environment. Rats were implanted with a catheter in the femoral vein using methods previously described <xref rid="bib4" ref-type="bibr">[4]</xref>. Five days later, rats received 0.9% saline or mCPP (Sigma, MO) dissolved in 0.9% saline (0.5, 2.5, or 5.0 mg/kg, i.v.; total volume injected = 0.25 ml; <italic>n</italic> = 4–5 rats per treatment). Rats were treated at the onset of the dark cycle and food intake was measured for the next 2 h. We observed that mCPP significantly and dose-dependently reduced chow intake compared to saline treatment (<italic>F</italic>(3, 17) = 7.59, <italic>p</italic> &lt; 0.01; <xref rid="fig1" ref-type="fig">Fig. 1</xref>). Post hoc comparisons revealed that both 2.5 and 5.0 mg/kg of mCPP significantly decreased feeding compared to saline administration.</p>
    <p>We next sought to investigate specific brainstem regions contributing to the anorectic effect of mCPP. Immunohistochemistry (IHC) for <italic>c-fos</italic> immunoreactivity (FOS-IR) was performed. Rats were deeply anesthetized with chloral hydrate (7%, 350 mg/kg, i.v.) and perfused transcardially with 0.9% saline followed by phosphate-buffed 10% formalin (pH 7.0, Sigma). Brains were removed, post-fixed with 10% formalin for 4 h and submerged overnight in 20% sucrose in phosphate-buffered saline (PBS). Brains were sectioned coronally on a freezing sliding microtome at 25 μm and collected in 6 equal series of adjacent tissue.</p>
    <p>IHC was performed as previously described <xref rid="bib4 bib5" ref-type="bibr">[4,5]</xref>. Briefly, tissue was pretreated in 0.3% H<sub>2</sub>O<sub>2</sub> for 1 h to block endogenous peroxidase and then incubated with a rabbit anti-FOS antibody (1:10,000 concentration, Calbiochem) in 0.3% normal donkey serum and PBT (0.04% Triton X-100 in PBS) with 0.02% sodium azide (PBT-azide) overnight at room temperature. Next, sections were incubated for 1.5 h with biotinylated donkey anti-rabbit serum (1:500, Jackson Laboratories) in 0.3% normal donkey serum and PBT (0.04% Triton X-100 in PBS). Following this, sections were incubated with an avidin-peroxidase complex (ABC, Vector Elite kit; 1:250, Vector Laboratories) for 1 h in PBT. The immunoperoxidase was developed in 0.04% 3, 3′-diaminobenzidine tetrahydrochloride (DAB; Sigma) and 0.003% hydrogen peroxide in PBS. Each step was preceded by a 15 min PBS rinse. The DAB reaction was terminated within 6–12 min by rinsing with PBS. The sections were mounted onto polysine slides, air-dried, dehydrated in ascending concentrations of ethanol, cleared in xylene and cover-slipped with mounting medium (Micromount, Surgipath).</p>
    <p>A qualitative survey of the distribution of FOS-IR in the NTS was performed (<xref rid="fig2" ref-type="fig">Fig. 2</xref>). Further quantitative analysis of FOS-IR induction was conducted at six selected levels of the NTS (<xref rid="fig3" ref-type="fig">Fig. 3</xref>), corresponding to −11.28 mm, −12.24 mm, −12.60 mm, −13.56 mm, −14.04 mm, and −15.00 mm from bregma based on the Paxinos and Watson rat brain atlas <xref rid="bib20" ref-type="bibr">[20]</xref>. Cell counts were restricted to the NTS based on Nissl staining of adjacent sections. Cells were counted manually.</p>
    <p>We observed that hypophagic doses of mCPP significantly and dose-dependently increased FOS-IR in the NTS only at levels −13.56 mm from bregma (<italic>F</italic>(3, 17) = 18.58, <italic>p</italic> &lt; 0.0001; <xref rid="fig3" ref-type="fig">Fig. 3</xref>D) and −14.04 mm from bregma (<italic>F</italic>(3, 17) = 16.76, <italic>p</italic> &lt; 0.0001; <xref rid="fig3" ref-type="fig">Fig. 3</xref>E). Post hoc analyses revealed that 0.5–5.0 mg/kg of mCPP significantly differed from saline treatment (<xref rid="app1" ref-type="sec">Fig. S1</xref>, −14.04 mm from bregma displayed). Pearson product moment correlation analysis revealed a strong negative correlation between food intake and NTS FOS-IR at −14.04 mm from bregma (<italic>r</italic> = −0.85, <italic>p</italic> &lt; 0.05). These data indicate that mCPP induces FOS-IR in a discrete subregion of the NTS, and that this activation is strongly negatively correlated with food intake.</p>
    <p>Distributed in a pattern consistent with the FOS-IR induced by mCPP treatment is a cluster of catecholamine-containing neurons previously demonstrated to be responsive to nutritional status <xref rid="bib23 bib24 bib34" ref-type="bibr">[23,24,34]</xref>. We therefore investigated whether mCPP significantly affects the activity of these neurons using dual-label IHC, with tyrosine hydroxilase immunoreactivity (TH-IR) used to identify catecholamine-containing neurons and FOS-IR as a marker of neuronal activation. Standard dual-label IHC procedures were used, as previously reported <xref rid="bib35" ref-type="bibr">[35]</xref>.</p>
    <p>Briefly, tissue was rinsed with PBS for 15 min, then incubated with rabbit anti-c-fos (1:1000, Calbiochem) and mouse anti-tyrosine hydroxylase (1:1000, Chemicon) antibodies in 0.3% normal donkey serum and PBT-azide overnight at room temperature. Next, sections were incubated for 1 h with biotinylated donkey anti-mouse serum (1:500, Jackson Laboratories) in 0.3% normal donkey serum and PBT. Sections were then incubated for 1 h with appropriate fluorophores, Alexa fluor 594 conjugated to streptavidin (1:1000, Molecular Probes) and Alexa fluor 488 conjugated to donkey–anti-rabbit IgG (1:500, Molecular Probes). Finally, sections were mounted onto polysine slides, air-dried, and coverslipped with Vectashield mounting medium (Vector Laboratories). For dual-label IHC, the NTS at the level of the area postrema, between −13.56 mm and −14.04 mm from bregma, was analyzed. Only unequivocal perikarya were counted as positive for TH-IR and only unequivocal nuclei were counted as positive for FOS-IR.</p>
    <p>mCPP significantly and substantially induced FOS-IR in TH-IR expressing neurons (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B and D) compared to vehicle treatment (<xref rid="fig4" ref-type="fig">Fig. 4</xref>A and C) at −13.56 mm to −14.04 mm from bregma. Specifically, mCPP activated 83.7 ± 15.0% (mean ± S.E.M.) of TH-IR containing neurons, whereas saline treatment induced FOS-IR in less than 1% of TH-IR containing neurons. Pearson product moment correlation analysis revealed a strong negative correlation between food intake and proportion of NTS TH-IR neurons that contained FOS-IR at −14.04 mm from bregma (<italic>r</italic> = −0.89, <italic>p</italic> &lt; 0.01). These data indicate that mCPP is highly effective in activating catecholamine-containing neurons in the NTS at the level of the area postrema, and that the extent of this activation is strongly negatively correlated with food intake.</p>
    <p>To determine whether the activation of NTS catecholaminergic neurons is selective, colocalization of FOS-IR with populations of neurons in the NTS containing other neuropeptides with anorectic effects – cholecystokinin (CCK), cocaine- and amphetamine-regulated transcript (CART), neurotensin, and glucagon-like peptide 1 (GLP-1) – was assessed. The same dual-label approach was used with different primary antibodies (rabbit anti-CCK, Chemicon, 1:2000; rabbit anti-CART, Phoenix, 1:2000; rabbit anti-neurotensin, Immunostar, 1:2000; rabbit anti-GLP-1, Bachem, 1:2000; and/or goat-anti-c-fos, Santa Cruz, 1:1000).</p>
    <p>CCK, CART, neurotensin, and GLP-1 containing neurons, were not activated by mCPP treatment, with less than 1% of each of these populations showing FOS-IR at any level of the NTS. The lack of coexpression of CART with c-fos after mCPP treatment is shown in <xref rid="app1" ref-type="sec">Fig. S2</xref>, while corresponding results for neurotensin are shown in <xref rid="app1" ref-type="sec">Fig. S3</xref>. Neither CCK nor GLP-1 are expressed at the levels of the NTS where c-fos induction is observed following mCPP, so no dual-labeling was observed with these neuropeptides (data not shown). Thus, the observed activation of NTS catecholeminergic neurons by mCPP is a selective effect.</p>
    <p>The 5-HTRs most likely modulating mCPP’s effects on ingestive behavior in the NTS are the 5-HT<sub>2C</sub>Rs and/or 5-HT<sub>1B</sub>Rs since these receptors are critically involved in the serotonergic regulation of food intake and they are expressed in the caudal NTS <xref rid="bib11 bib18 bib19" ref-type="bibr">[11,18,19]</xref>. However, mCPP also has binding affinity for the 5-HT<sub>3</sub>Rs, and activation of these receptors in the NTS may also play a role in mCPP hypophagia <xref rid="bib7" ref-type="bibr">[7]</xref>.</p>
    <p>TH-containing neurons in the caudal NTS are evident in the mainly noradrenergic A2 cell group and, more rostrally, the mainly adrenergic C2 cell group <xref rid="bib1 bib33" ref-type="bibr">[1,33]</xref>. These neurons appear to play an important role in the regulation of energy homeostasis. Gastric distension activates catecholaminergic neurons in the NTS <xref rid="bib34" ref-type="bibr">[34]</xref> at a similar site to the maximal activation seen with mCPP. Specifically, 10–30% of NTS neurons positive for dopamine β-hydroxylase (DBH), which may be noradrenergic or adrenergic, were activated, depending on the degree of distension. In addition, satiating meals activated 25–35% of NTS TH neurons <xref rid="bib23" ref-type="bibr">[23]</xref>. We performed neurochemical colocalization of TH-IR and mCPP-induced FOS-IR, and observed that the vast majority of TH-IR neurons in the NTS at the level of the area postrema, which includes A2, were activated by mCPP.</p>
    <p>NTS TH neurons constitute a major ascending pathway through which vagal sensory information reaches the hypothalamus. In particular, neurons in the A2 region constitute one of the principal catecholaminergic inputs to the PVH and LHA <xref rid="bib29 bib30" ref-type="bibr">[29,30]</xref>. Previous work in our laboratory has implicated hypothalamic centers in the anorectic actions of serotonin <xref rid="bib9 bib10 bib16" ref-type="bibr">[9,10,16]</xref>. However, studies showing anorectic effects of mCPP and <sc>d</sc>-fenfluramine in decerebrate rats <xref rid="bib8 bib12" ref-type="bibr">[8,12]</xref> suggest that serotonin can also modulate food intake by engaging brainstem receptors. Serotonin thus appears to affect food intake both at the level of reflex brainstem circuits and integrative hypothalamic systems. Further study is required to clarify these distinct actions and the relationship between them, and the role of NTS catecholaminergic neurons in either or both of these satiety networks.</p>
    <p>In conclusion, we have shown that the classic serotonin receptor agonist mCPP selectively activates a specific subset of catecholaminergic neurons in the NTS at the level of the area postrema. These neurons play a key role in the integration of visceral satiety signals and may be involved in mediating brainstem reflex satiety circuits and/or in conveying visceral satiety signals to hypothalamic integration sites. The findings presented here provide additional insight into neural circuitry underlying the serotonergic modulation of ingestive behavior.</p>
    <sec sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p>Supplementary data associated with this article can be found, in the online version, at <ext-link xlink:href="doi:10.1016/j.bbr.2008.07.039" ext-link-type="uri">doi:10.1016/j.bbr.2008.07.039</ext-link>.</p>
    </sec>
    <sec id="app1" sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p>
        <supplementary-material content-type="local-data" id="N0x1c67400N0x2d5b600">
          <caption>
            <title>Fig. S1</title>
          </caption>
          <p>mCPP dose-dependently induced FOS-IR in the NTS. (A and E) 0.9% saline, (B and F) 0.5 mg/kg mCPP, (C and G) 2.5 mg/kg mCPP, or (D and H) 5.0 mg/kg mCPP were administered i.v. at the onset of the dark cycle and 2 h later, rats were euthanized, brains extracted, prepared, and process for FOS-IR. At doses effective in reducing food intake, mCPP induced substantial and dose-dependent FOS-IR in a discrete region of the NTS corresponding to the level of the area postrema (distance from bregma −13.56 to −14.40). Displayed are representative photomicrographs of the NTS. E–H show enlarged areas represented in boxes in A–D. CC, central canal; AP, area postrema. Scale bar panel C, 1 mm applies to A–C; scale bar panel F, 100 μm applies to D–F.</p>
          <media xlink:href="mmc1.jpg" mimetype="text" mime-subtype="plain"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="N0x1c67400N0x2d5b780">
          <caption>
            <title>Fig. S2</title>
          </caption>
          <p>mCPP did not induce FOS-IR in NTS CART-IR neurons. Dual-label IHC for c-fos (green nuclei) and CART (red perikarya and fibers) was performed on tissue from rats treated with either 0.9% saline (SAL) or mCPP (2.5 mg/kg) (<italic>n</italic> = 4–5 per treatment). Merged photomicrographs of images of the individual fluorescent labels are shown. The images are from representative sections at the level of the area postrema (−13.56 mm to −14.04 mm from bregma). (A) Lack of c-fos expression in a rat treated with saline. Minimal CART-IR perikarya, but abundant CART-IR fibers, are found at this level of the NTS. (B) c-fos expression in NTS neurons, but not CART-IR perikarya, in a rat treated with 2.5 mg/kg mCPP. (C and D) Enlarged area represented in box in panels A and B, respectively. CC, central canal; AP, area postrema. Scale bar panel B, 100 μm, applies to (A) and (B); scale bar panel D, 20 μm, applies to (C) and (D).</p>
          <media xlink:href="mmc2.jpg" mimetype="text" mime-subtype="plain"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="N0x1c67400N0x2d5b960">
          <caption>
            <title>Fig. S3</title>
          </caption>
          <p>mCPP did not induce FOS-IR in NTS neurotensin-IR neurons. Dual-label IHC for c-fos (green nuclei) and neurotensin (NT, red perikarya and fibers) was performed on tissue from rats treated with either 0.9% saline (SAL) or mCPP (2.5 mg/kg) (<italic>n</italic> = 4–5 per treatment). Merged photomicrographs of images of the individual fluorescent labels are shown. The images are from representative sections at the level of the area postrema (−13.56 mm to −14.04 mm from bregma). (A) Lack of c-fos expression in a rat treated with saline. (B) c-fos expression in NTS neurons, but not neurotensin-IR perikarya, in a rat treated with 2.5 mg/kg mCPP. (C and D) Enlarged area represented in box in panels A and B, respectively. CC, central canal; AP, area postrema. Scale bar panel B, 100 μm, applies to (A) and (B); scale bar panel D, 20 μm, applies to (C) and (D).</p>
          <media xlink:href="mmc3.jpg" mimetype="text" mime-subtype="plain"/>
        </supplementary-material>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was supported by the Gates Cambridge Trust (D.D.L.) and the NIDDK DK065171, TANITA Healthy Weight Community Trust, and Wellcome Trust (L.K.H.).</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>[1]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armstrong</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Pickel</surname>
              <given-names>V.M.</given-names>
            </name>
            <name>
              <surname>Joh</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>D.J.</given-names>
            </name>
          </person-group>
          <article-title>Distribution of dopamine-, noradrenaline-, and adrenaline-containing cell bodies in the rat medulla oblongata: demonstrated by the immunocytochemical localization of catecholamine biosynthetic enzymes</article-title>
          <source>J Comp Neurol</source>
          <year>1982</year>
          <volume>212</volume>
          <fpage>173</fpage>
          <lpage>187</lpage>
          <pub-id pub-id-type="pmid">6142061</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <label>[2]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bovetto</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Richard</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Functional assessment of the 5-HT 1A-, 1B-, 2A/2C-, and 3-receptor subtypes on food intake and metabolic rate in rats</article-title>
          <source>Am J Physiol</source>
          <year>1995</year>
          <volume>268</volume>
          <fpage>R14</fpage>
          <lpage>R20</lpage>
          <pub-id pub-id-type="pmid">7840314</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <label>[3]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Breisch</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Zemlan</surname>
              <given-names>F.P.</given-names>
            </name>
            <name>
              <surname>Hoebel</surname>
              <given-names>B.G.</given-names>
            </name>
          </person-group>
          <article-title>Hyperphagia and obesity following serotonin depletion by intraventricular p-chlorophenylalanine</article-title>
          <source>Science</source>
          <year>1976</year>
          <volume>192</volume>
          <fpage>382</fpage>
          <lpage>385</lpage>
          <pub-id pub-id-type="pmid">130678</pub-id>
        </citation>
      </ref>
      <ref id="bib4">
        <label>[4]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elmquist</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Saper</surname>
              <given-names>C.B.</given-names>
            </name>
          </person-group>
          <article-title>Activation of neurons projecting to the paraventricular hypothalamic nucleus by intravenous lipopolysaccharide</article-title>
          <source>J Comp Neurol</source>
          <year>1996</year>
          <volume>374</volume>
          <fpage>315</fpage>
          <lpage>331</lpage>
          <pub-id pub-id-type="pmid">8906501</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <label>[5]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elmquist</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Scammell</surname>
              <given-names>T.E.</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Saper</surname>
              <given-names>C.B.</given-names>
            </name>
          </person-group>
          <article-title>Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration</article-title>
          <source>J Comp Neurol</source>
          <year>1996</year>
          <volume>371</volume>
          <fpage>85</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="pmid">8835720</pub-id>
        </citation>
      </ref>
      <ref id="bib6">
        <label>[6]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fraser</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Davison</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Meal-induced c-fos expression in brain stem is not dependent on cholecystokinin release</article-title>
          <source>Am J Physiol</source>
          <year>1993</year>
          <volume>265</volume>
          <fpage>R235</fpage>
          <lpage>R239</lpage>
          <pub-id pub-id-type="pmid">8342693</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <label>[7]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glennon</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Ismaiel</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>B.G.</given-names>
            </name>
            <name>
              <surname>Peroutka</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study</article-title>
          <source>Eur J Pharmacol</source>
          <year>1989</year>
          <volume>168</volume>
          <fpage>387</fpage>
          <lpage>392</lpage>
          <pub-id pub-id-type="pmid">2583244</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <label>[8]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grill</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Donahey</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Contribution of caudal brainstem to d-fenfluramine anorexia</article-title>
          <source>Psychopharmacology (Berlin)</source>
          <year>1997</year>
          <volume>130</volume>
          <fpage>375</fpage>
          <lpage>381</lpage>
          <pub-id pub-id-type="pmid">9160854</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <label>[9]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heisler</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Cowley</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Tecott</surname>
              <given-names>L.H.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Low</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Smart</surname>
              <given-names>J.L.</given-names>
            </name>
          </person-group>
          <article-title>Activation of central melanocortin pathways by fenfluramine</article-title>
          <source>Science</source>
          <year>2002</year>
          <volume>297</volume>
          <fpage>609</fpage>
          <lpage>611</lpage>
          <pub-id pub-id-type="pmid">12142539</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <label>[10]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heisler</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Jobst</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Sutton</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Borok</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Thornton-Jones</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Serotonin reciprocally regulates melanocortin neurons to modulate food intake</article-title>
          <source>Neuron</source>
          <year>2006</year>
          <volume>51</volume>
          <fpage>239</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="pmid">16846858</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <label>[11]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoffman</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Mezey</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain</article-title>
          <source>FEBS Lett</source>
          <year>1989</year>
          <volume>247</volume>
          <fpage>453</fpage>
          <lpage>462</lpage>
          <pub-id pub-id-type="pmid">2714444</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <label>[12]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaplan</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Grill</surname>
              <given-names>H.J.</given-names>
            </name>
          </person-group>
          <article-title>Serotonin receptors in the caudal brainstem are necessary and sufficient for the anorectic effect of peripherally administered mCPP</article-title>
          <source>Psychopharmacology (Berlin)</source>
          <year>1998</year>
          <volume>137</volume>
          <fpage>43</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">9631955</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <label>[13]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kennett</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Curzon</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors</article-title>
          <source>Psychopharmacology (Berlin)</source>
          <year>1988</year>
          <volume>96</volume>
          <fpage>93</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">2906446</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <label>[14]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kennett</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Curzon</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Potencies of antagonists indicate that 5-HT1C receptors mediate 1–3(chlorophenyl)piperazine-induced hypophagia</article-title>
          <source>Br J Pharmacol</source>
          <year>1991</year>
          <volume>103</volume>
          <fpage>2016</fpage>
          <lpage>2020</lpage>
          <pub-id pub-id-type="pmid">1912990</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <label>[15]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitchener</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Dourish</surname>
              <given-names>C.T.</given-names>
            </name>
          </person-group>
          <article-title>An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats</article-title>
          <source>Psychopharmacology (Berlin)</source>
          <year>1994</year>
          <volume>113</volume>
          <fpage>369</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="pmid">7862847</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <label>[16]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lam</surname>
              <given-names>D.D.</given-names>
            </name>
            <name>
              <surname>Przydzial</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Ridley</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Yeo</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>Rochford</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>O’Rahilly</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors</article-title>
          <source>Endocrinology</source>
          <year>2008</year>
          <volume>149</volume>
          <fpage>1323</fpage>
          <lpage>1328</lpage>
          <pub-id pub-id-type="pmid">18039773</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <label>[17]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>B.H.</given-names>
            </name>
            <name>
              <surname>Rowland</surname>
              <given-names>N.E.</given-names>
            </name>
          </person-group>
          <article-title>Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats</article-title>
          <source>Brain Res Bull</source>
          <year>1993</year>
          <volume>31</volume>
          <fpage>43</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="pmid">8453494</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <label>[18]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manaker</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Verderame</surname>
              <given-names>H.M.</given-names>
            </name>
          </person-group>
          <article-title>Organization of serotonin 1A and 1B receptors in the nucleus of the solitary tract</article-title>
          <source>J Comp Neurol</source>
          <year>1990</year>
          <volume>301</volume>
          <fpage>535</fpage>
          <lpage>553</lpage>
          <pub-id pub-id-type="pmid">2148752</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <label>[19]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molineaux</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Jessell</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Axel</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Julius</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1989</year>
          <volume>86</volume>
          <fpage>6793</fpage>
          <lpage>6797</lpage>
          <pub-id pub-id-type="pmid">2771958</pub-id>
        </citation>
      </ref>
      <ref id="bib20">
        <label>[20]</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Paxinos</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>The rat brain in stereotaxic coordinates</article-title>
          <edition>5th ed.</edition>
          <year>2005</year>
          <publisher-name>Elsevier</publisher-name>
        </citation>
      </ref>
      <ref id="bib21">
        <label>[21]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Powley</surname>
              <given-names>T.L.</given-names>
            </name>
          </person-group>
          <article-title>Vagal circuitry mediating cephalic-phase responses to food</article-title>
          <source>Appetite</source>
          <year>2000</year>
          <volume>34</volume>
          <fpage>184</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">10744908</pub-id>
        </citation>
      </ref>
      <ref id="bib22">
        <label>[22]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raybould</surname>
              <given-names>H.E.</given-names>
            </name>
            <name>
              <surname>Gayton</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Dockray</surname>
              <given-names>G.J.</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat</article-title>
          <source>J Neurosci</source>
          <year>1988</year>
          <volume>8</volume>
          <fpage>3018</fpage>
          <lpage>3024</lpage>
          <pub-id pub-id-type="pmid">3411366</pub-id>
        </citation>
      </ref>
      <ref id="bib23">
        <label>[23]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rinaman</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>G.E.</given-names>
            </name>
            <name>
              <surname>Stricker</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Verbalis</surname>
              <given-names>J.G.</given-names>
            </name>
          </person-group>
          <article-title>Medullary c-Fos activation in rats after ingestion of a satiating meal</article-title>
          <source>Am J Physiol</source>
          <year>1998</year>
          <volume>275</volume>
          <fpage>R262</fpage>
          <lpage>R268</lpage>
          <pub-id pub-id-type="pmid">9688987</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <label>[24]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rinaman</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Verbalis</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Stricker</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>G.E.</given-names>
            </name>
          </person-group>
          <article-title>Distribution and neurochemical phenotypes of caudal medullary neurons activated to express cFos following peripheral administration of cholecystokinin</article-title>
          <source>J Comp Neurol</source>
          <year>1993</year>
          <volume>338</volume>
          <fpage>475</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="pmid">8132858</pub-id>
        </citation>
      </ref>
      <ref id="bib25">
        <label>[25]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rogers</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Hermann</surname>
              <given-names>G.E.</given-names>
            </name>
          </person-group>
          <article-title>Gastric-vagal solitary neurons excited by paraventricular nucleus microstimulation</article-title>
          <source>J Auton Nerv Syst</source>
          <year>1985</year>
          <volume>14</volume>
          <fpage>351</fpage>
          <lpage>362</lpage>
          <pub-id pub-id-type="pmid">4086724</pub-id>
        </citation>
      </ref>
      <ref id="bib26">
        <label>[26]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rowland</surname>
              <given-names>N.E.</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rema</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B/2C agonists in rats</article-title>
          <source>Psychopharmacology (Berlin)</source>
          <year>2001</year>
          <volume>156</volume>
          <fpage>108</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="pmid">11465628</pub-id>
        </citation>
      </ref>
      <ref id="bib27">
        <label>[27]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saller</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Stricker</surname>
              <given-names>E.M.</given-names>
            </name>
          </person-group>
          <article-title>Hyperphagia and increased growth in rats after intraventricular injection of 5,7-dihydroxytryptamine</article-title>
          <source>Science</source>
          <year>1976</year>
          <volume>192</volume>
          <fpage>385</fpage>
          <lpage>387</lpage>
          <pub-id pub-id-type="pmid">1257774</pub-id>
        </citation>
      </ref>
      <ref id="bib28">
        <label>[28]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samanin</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Mennini</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ferraris</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bendotti</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Borsini</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Garattini</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats</article-title>
          <source>Naunyn Schmiedebergs Arch Pharmacol</source>
          <year>1979</year>
          <volume>308</volume>
          <fpage>159</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">503247</pub-id>
        </citation>
      </ref>
      <ref id="bib29">
        <label>[29]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sawchenko</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Swanson</surname>
              <given-names>L.W.</given-names>
            </name>
          </person-group>
          <article-title>Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses</article-title>
          <source>Science</source>
          <year>1981</year>
          <volume>214</volume>
          <fpage>685</fpage>
          <lpage>687</lpage>
          <pub-id pub-id-type="pmid">7292008</pub-id>
        </citation>
      </ref>
      <ref id="bib30">
        <label>[30]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sawchenko</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Swanson</surname>
              <given-names>L.W.</given-names>
            </name>
          </person-group>
          <article-title>The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat</article-title>
          <source>Brain Res</source>
          <year>1982</year>
          <volume>257</volume>
          <fpage>275</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="pmid">6756545</pub-id>
        </citation>
      </ref>
      <ref id="bib31">
        <label>[31]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shor-Posner</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Grinker</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Marinescu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Leibowitz</surname>
              <given-names>S.F.</given-names>
            </name>
          </person-group>
          <article-title>Hypothalamic serotonin in the control of meal patterns and macronutrient selection</article-title>
          <source>Brain Res Bull</source>
          <year>1986</year>
          <volume>17</volume>
          <fpage>663</fpage>
          <lpage>671</lpage>
          <pub-id pub-id-type="pmid">3801928</pub-id>
        </citation>
      </ref>
      <ref id="bib32">
        <label>[32]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simansky</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Vaidya</surname>
              <given-names>A.H.</given-names>
            </name>
          </person-group>
          <article-title>Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists</article-title>
          <source>Brain Res Bull</source>
          <year>1990</year>
          <volume>25</volume>
          <fpage>953</fpage>
          <lpage>960</lpage>
          <pub-id pub-id-type="pmid">2149668</pub-id>
        </citation>
      </ref>
      <ref id="bib33">
        <label>[33]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swanson</surname>
              <given-names>L.W.</given-names>
            </name>
            <name>
              <surname>Hartman</surname>
              <given-names>B.K.</given-names>
            </name>
          </person-group>
          <article-title>The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker</article-title>
          <source>J Comp Neurol</source>
          <year>1975</year>
          <volume>163</volume>
          <fpage>467</fpage>
          <lpage>505</lpage>
          <pub-id pub-id-type="pmid">1100685</pub-id>
        </citation>
      </ref>
      <ref id="bib34">
        <label>[34]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Willing</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Berthoud</surname>
              <given-names>H.R.</given-names>
            </name>
          </person-group>
          <article-title>Gastric distension-induced c-fos expression in catecholaminergic neurons of rat dorsal vagal complex</article-title>
          <source>Am J Physiol</source>
          <year>1997</year>
          <volume>272</volume>
          <fpage>R59</fpage>
          <lpage>R67</lpage>
          <pub-id pub-id-type="pmid">9038991</pub-id>
        </citation>
      </ref>
      <ref id="bib35">
        <label>[35]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sutton</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Rochford</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Semple</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>D.D.</given-names>
            </name>
            <name>
              <surname>Oksanen</surname>
              <given-names>L.J.</given-names>
            </name>
          </person-group>
          <article-title>Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways</article-title>
          <source>Cell Metab</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>398</fpage>
          <lpage>405</lpage>
          <pub-id pub-id-type="pmid">17983585</pub-id>
        </citation>
      </ref>
      <ref id="bib36">
        <label>[36]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zittel</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>De Giorgio</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sternini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Raybould</surname>
              <given-names>H.E.</given-names>
            </name>
          </person-group>
          <article-title>Fos protein expression in the nucleus of the solitary tract in response to intestinal nutrients in awake rats</article-title>
          <source>Brain Res</source>
          <year>1994</year>
          <volume>663</volume>
          <fpage>266</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="pmid">7874510</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>mCPP significantly and dose-dependently reduced 2 h food intake in rats. 0.9% saline (white bar) or mCPP at doses of 0.5 (light gray bar), 2.5 (dark gray bar), or 5.0 (black bar) mg/kg were administered i.v. at the onset of the dark cycle and food intake over the next 2 h was measured. Data are presented as mean ± S.E.M., **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001 compared to saline treatment.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>Distribution of mCPP-induced FOS-IR in the NTS. (A–F) 0.9% saline or (G-L) 5.0 mg/kg mCPP were administered i.v. at the onset of the dark cycle and 2 h later, rats were euthanized, brains extracted, prepared, and processed for FOS-IR. Displayed are representative photomicrographs of the nucleus of the solitary tract (NTS). Distances from bregma are (A and G) −11.28 mm, (B and H) −12.24 mm, (C and I) −12.60 mm, (D and J) −13.56 mm, (E and K) −14.04 mm and (F and L) −15.00 mm. mCPP selectively induced FOS-IR in a discrete region of the NTS (distance from bregma −13.56 mm to −14.40 mm) corresponding to the level of the area postrema (AP). Scale bar panel L, 1 mm, applies to (A)–(L).</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>mCPP-hypophagia was associated with a significant induction of FOS-IR in the NTS. Counts of FOS-IR (n) induction in the NTS following treatment with 0.9% saline (white bar) or mCPP at doses of 0.5 (light gray bar), 2.5 (dark gray bar), or 5.0 (black bar) mg/kg, i.v. mCPP significantly increased FOS-IR in the NTS at −12.60 mm to −14.04 mm from bregma compared to saline treatment. Data are presented as mean ± S.E.M., *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001 compared to saline treatment.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Fig. 4</label>
      <caption>
        <p>mCPP induced FOS-IR in NTS TH-IR neurons. Dual-label IHC for c-fos (green nuclei) and TH (red perikarya and fibers) was performed on tissue from rats treated with either 0.9% saline (SAL) or mCPP (2.5 mg/kg) (<italic>n</italic> = 4–5 per treatment). Merged photomicrographs of images of the individual fluorescent labels are shown. The images are from representative sections at the level of the area postrema (−13.56 mm to −14.04 mm from bregma). (A) Lack of c-fos expression in a rat treated with saline. (B) c-fos expression in NTS TH perikarya (yellow regions of colocalization) in a rat treated with 2.5 mg/kg mCPP. (C and D) Enlarged area represented in box in panels A and B, respectively. CC, central canal; AP, area postrema. Scale bar panel B, 100 μm, applies to (A) and (B); scale bar panel D, 20 μm, applies to (C) and (D).</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
  </floats-wrap>
</article>